COVID-19 -- Brazil
The Pfizer-BioNTech coronavirus vaccine is extremely effective in young adolescents, perhaps even more so than in adults, the companies reported on Wednesday -- a finding that could ease the return to normalcy for millions of American families.
No symptomatic infections were found among children aged 12 to 15 who received the vaccine in a recent clinical trial, the drug makers said; the children produced strong antibody responses and experienced no serious side effects.
Depending on
Read more about it at HealthMap Global Disease Alerts via http://healthmap.org/ln.php?8283365&promed&0
No comments:
Post a Comment